S-217622

ensitrelvir · Shionogi & Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for S-217622, covering 2025-05-04 to 2026-08-20. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 [Phase 3]